These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25024919)

  • 21. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy.
    Hamzat H; Sun H; Ford JC; Macleod J; Soiza RL; Mangoni AA
    Drugs Aging; 2012 Aug; 29(8):681-90. PubMed ID: 22775478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study.
    Haroon M; Yasin F; Gardezi SK; Adeeb F; Walker F
    JRSM Short Rep; 2013; 4(8):2042533313497183. PubMed ID: 24040498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China.
    Luo H; Fan Q; Bian T; Li X; Chen K; Zhang Q; Wei Y; Xiao Y; Li Y
    BMC Health Serv Res; 2019 Nov; 19(1):880. PubMed ID: 31752835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitor co-prescription with dual antiplatelet therapy among patients with acute coronary syndrome in Qatar.
    Awaisu A; Hamou F; Mekideche L; El Muabby N; Mahfouz A; Mohammed S; Saad A
    Int J Clin Pharm; 2016 Apr; 38(2):353-61. PubMed ID: 26749343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irrational use of proton pump inhibitors in general practise.
    Ali O; Poole R; Okon M; Maunick S; Troy E
    Ir J Med Sci; 2019 May; 188(2):541-544. PubMed ID: 30136221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge.
    Leri F; Ayzenberg M; Voyce SJ; Klein A; Hartz L; Smego RA
    South Med J; 2013 Apr; 106(4):270-3. PubMed ID: 23558416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate prescribing of proton pump inhibitors in primary care.
    Batuwitage BT; Kingham JG; Morgan NE; Bartlett RL
    Postgrad Med J; 2007 Jan; 83(975):66-8. PubMed ID: 17267683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly Patients.
    Voukelatou P; Vrettos I; Emmanouilidou G; Dodos K; Skotsimara G; Kontogeorgou D; Kalliakmanis A
    Curr Gerontol Geriatr Res; 2019; 2019():7591045. PubMed ID: 30713553
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thesaurus of pharmacist interventions associated with inappropriate proton pump inhibitors prescriptions].
    Veremme L; Baudouin A; Janoly-Dumenil A; Charpiat B
    Ann Pharm Fr; 2023 May; 81(3):552-567. PubMed ID: 36375534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
    Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
    Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
    Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
    J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the Inappropriate Use of Proton Pump Inhibitors in an Internal Medicine Residency Clinic.
    Boster J; Lowry LE; Bezzant ML; Kuiper B; Surry L
    Cureus; 2020 Jan; 12(1):e6609. PubMed ID: 32064190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use.
    Law JK; Andrews CN; Enns R
    Gastrointest Endosc; 2009 Jan; 69(1):3-9. PubMed ID: 18718583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use and management of proton pump inhibitors: An observational study].
    Gramont B; Bertoletti L; Roy M; Roblin X; Tardy B; Cathébras P
    Therapie; 2020; 75(6):649-662. PubMed ID: 32591130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overuse of proton pump inhibitors for stress ulcer prophylaxis in Jordan.
    Alqudah MA; Al-Azzam S; Alzoubi K; Alkhatatbeh M; Rawashdeh N
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):597-602. PubMed ID: 27125772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.